MENA Metabolic Conference
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: E-News

E-News

Antibodies Stewart Newlove

Antibodies.com scales operations with huge expansion of Cambridge headquarters

, 22 August 2025/in E-News /by panglobal

Biological reagent supplier Antibodies.com has made a strategic relocation to Cambridge Technopark, which reflects sustained global growth, with its customer base tripling over five years to serve over 5,000 research institutions worldwide across more than 100 countries.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/08/Antibodies-Stewart-Newlove.jpg 1920 1357 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-08-22 11:43:182025-08-22 11:43:18Antibodies.com scales operations with huge expansion of Cambridge headquarters
Novo Nordisk Doustdar

Novo Nordisk appoints new chief executive as pharma giant restructures R&D operations

, 22 August 2025/in E-News /by panglobal

Danish pharmaceutical giant Novo Nordisk has appointed Maziar Mike Doustdar as chief executive officer, bringing his proven track record of doubling international sales over the past decade. The leadership transition coincides with strategic R&D consolidation as the company positions itself to address rapidly developing diabetes and obesity markets.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/08/Novo-Nordisk-Doustdar.jpg 1158 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-08-22 11:38:152025-08-22 11:38:15Novo Nordisk appoints new chief executive as pharma giant restructures R&D operations
Scherm­afbeelding 2025 08 22 om 13.26.24

Enhanced Genomics partnership unlocks hidden Alzheimer’s targets through breakthrough 3D multi-omics

, 22 August 2025/in E-News /by panglobal

Enhanced Genomics has partnered with Cambridge University’s ALBORADA Drug Discovery Institute to identify novel therapeutic targets for Alzheimer’s disease using advanced 3D multi-omics technology. The collaboration has already yielded multiple previously undetectable targets, potentially accelerating drug discovery timelines across neurodegenerative diseases.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/08/Scherm­afbeelding-2025-08-22-om-13.26.24.jpg 600 1560 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-08-22 11:31:122025-08-22 11:33:41Enhanced Genomics partnership unlocks hidden Alzheimer’s targets through breakthrough 3D multi-omics
LogicalAntigen

Logical Biological launches sister company to accelerate diagnostic antigen development

, 22 August 2025/in E-News /by panglobal

Logical Biological has established Logical Antigen, a specialist sister company focused on rapid customisation of high-quality antigens and biological materials. The new venture addresses critical supply chain challenges in the IVD market, offering streamlined protein purification services that reduce traditional development timelines from years to weeks through innovative extraction and engineering techniques.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/08/LogicalAntigen.jpg 683 1024 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-08-22 10:54:432025-08-22 10:54:43Logical Biological launches sister company to accelerate diagnostic antigen development
Scherm­afbeelding 2025 08 22 om 12.47.49

DEBRA Research forms strategic alliance with Queen Mary University to accelerate epidermolysis bullosa therapeutics

, 22 August 2025/in E-News /by panglobal

Global nonprofit DEBRA Research has established a preclinical research collaboration with Queen Mary University of London to enhance drug development capabilities for epidermolysis bullosa, addressing critical bottlenecks in therapeutic advancement for this rare genetic skin disorder through innovative academic-philanthropic partnership models.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/08/Scherm­afbeelding-2025-08-22-om-12.47.49.png 828 1678 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-08-22 10:23:162025-08-22 10:48:25DEBRA Research forms strategic alliance with Queen Mary University to accelerate epidermolysis bullosa therapeutics
4basebio lab

Synthetic DNA manufacturer 4basebio rebrands as part of therapeutic expansion

, 22 August 2025/in E-News /by panglobal

Cambridge-based 4basebio has launched refreshed branding and a new website following its £40 million investment round, as the AIM-listed company positions itself for growth in synthetic DNA manufacturing for next-generation therapeutics including gene therapy, RNA therapeutics and vaccine development.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/08/4basebio_lab.jpg 1280 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-08-22 10:17:272025-08-22 10:17:27Synthetic DNA manufacturer 4basebio rebrands as part of therapeutic expansion
Cherwell Renamed AnalytiChem UK

Cherwell Laboratories completes strategic integration as AnalytiChem UK

, 22 August 2025/in E-News /by panglobal

Cherwell Laboratories, the established cleanroom microbiology specialist will transition to AnalytiChem UK from September 2025, marking the completion of its integration with the global AnalytiChem Group whilst maintaining its 54-year heritage in pharmaceutical manufacturing support and quality control solutions.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/08/Cherwell-Renamed-AnalytiChem-UK.jpg 546 1735 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-08-22 09:17:582025-08-22 09:49:24Cherwell Laboratories completes strategic integration as AnalytiChem UK
ARTBIO Emanuele Ostuni

ARTBIO secures $132 million series B funding for alpha radioligand therapy advancement

, 22 August 2025/in E-News /by panglobal

Clinical-stage radiopharmaceutical company ARTBIO has completed a substantial $132 million Series B financing round to advance its pipeline of alpha radioligand therapies, expand manufacturing capabilities, and support Phase II development of lead candidate AB001 for metastatic castration-resistant prostate cancer.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/08/ARTBIO_Emanuele_Ostuni.jpg 1192 1126 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-08-22 09:09:412025-08-22 09:09:41ARTBIO secures $132 million series B funding for alpha radioligand therapy advancement
GEA

GEA advances freeze-drying manufacturing with €80 million pharmaceutical technology centre

, 22 August 2025/in E-News /by panglobal

GEA’s new 40,000-square-metre facility in Elsdorf, Germany represents a strategic expansion into pharmaceutical freeze-drying systems, addressing surging global demand for vaccine and injectable drug manufacturing technologies. The investment demonstrates significant industry confidence in lyophilisation technology advancement.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/08/GEA.jpg 1077 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-08-22 07:38:282025-08-22 07:38:28GEA advances freeze-drying manufacturing with €80 million pharmaceutical technology centre
Takara Bio

Takara Bio secures European distribution deal with MACHEREY-NAGEL

, 22 July 2025/in E-News /by panglobal

Japanese molecular biology company Takara Bio Europe has partnered with German analytical products manufacturer MACHEREY-NAGEL to distribute bioanalysis solutions across 11 European markets, strengthening workflow integration capabilities for researchers conducting RNA, DNA, and protein purification studies.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2025/07/Takara-Bio.png 320 520 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2025-07-22 14:57:102025-07-22 14:57:10Takara Bio secures European distribution deal with MACHEREY-NAGEL
Page 9 of 231«‹7891011›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

March 2026

CLi Cover MRCH 2026
11 March 2026

Isomorphic Labs unveils IsoDDE, a unified AI drug design engine surpassing AlphaFold 3 in biomolecular prediction

11 March 2026

Androgen testing for PCOS diagnosis

9 March 2026

DiaSys Diagnostic Systems | ACE FS

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription